Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

DDX43 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 43)

Identity

Other namesHAGE (for Helicase AntiGEn)
DKFZp434H2114
Hugo DDX43
Location 6q13
Local_order between markers GATA11B08 and D6S284
Note This gene was isolated as a cDNA by applying a subtraction approach named representational difference analysis (RDA). Rhabdomyosarcoma LB23-SAR was used as the source of tester cDNA that was subtracted with driver cDNA, a mixture of human uterus, breast, heart, and colon cDNA.

DNA/RNA

Transcription The transcript is about 2.2 kb. Gene HAGE is weakly transcribed in normal tissues: the level of expression was estimated to represent only 0.2% of the level found in the LB23-SAR reference cell line. The only exception is testis, which shows a level of expression comparable to that of LB23-SAR. Gene HAGE was found to be expressed in 90 out of 383 tumor samples of different histological types, well above the level in normal tissues; about 5% of the positive samples showed a level of expression above 10% of the level of LB23-SAR, and 7% showed a level of expression between 1-10%. Expression of HAGE was induced in fibroblasts after treatment with the demethylating agent, 5-aza-2¹-deoxycytidine.

Protein

Description The largest open reading frame comprises 1,944 nucleotides and encodes a protein of 648 amino acids (72,871 Da). The pKi of the protein is 9.29.
Function Comparison with databases revealed that HAGE shows 55% similarity with the human p68 protein, an ATP-dependent RNA helicase that is a member of the DEAD-box proteins. Four motifs that are present in members of the DEAD box family are conserved in the HAGE protein. However, ATPase and helicase activities of HAGE were not demonstrated.

Mutations

Note No mutation was observed in the HAGE cDNA isolated from LB23-SAR.

Implicated in

Entity Tumors
Note HAGE expression can be induced by demethylating agent 5-azadeoxycytidine, suggesting that demethylation plays a role in the activation of these genes in tumors. Activation of HAGE in tumor cells most likely results therefore from the genome-wide demethylation process that is known to occur in these cells.
Oncogenesis HAGE is not the first case of a DEAD-box protein that is overexpressed in tumors. Moreover, it worth noting that one out of 42 discovered mutated human tumor antigens is produced by a point mutation in a gene named MUM-3. This gene encodes a protein with homology with members of the RNA helicase family. These observations suggest that mutated or overexpressed helicases may contribute to tumoral transformation or progression.
  

External links

Nomenclature
HugoDDX43
GDBDDX43
Entrez_GeneDDX43  55510  DEAD (Asp-Glu-Ala-Asp) box polypeptide 43
Cards
AtlasDDX43ID40288ch6q13
GeneCardsDDX43
EnsemblDDX43 [Search_View]   ENSG00000080007 [Gene_View]
GenatlasDDX43
GeneLynxDDX43
eGenomeDDX43
euGene55510
Genomic and cartography
GoldenPathDDX43  -  6q13   chr6:74161192-74183791 +  6q12-q13   [Description]    (hg18-Mar_2006)
EnsemblDDX43 - 6q12-q13 [CytoView]
NCBIMapview
OMIMDisease map [OMIM]
HomoloGeneDDX43
Gene and transcription
GenbankAJ278110 [ ENTREZ ]
GenbankAL136751 [ ENTREZ ]
GenbankAM393499 [ ENTREZ ]
GenbankBC056879 [ ENTREZ ]
GenbankBC066938 [ ENTREZ ]
RefSeqNM_018665 [ SRS ]    NM_018665 [ ENTREZ ]
RefSeqAC_000049 [ SRS ]    AC_000049 [ ENTREZ ]
RefSeqNC_000006 [ SRS ]    NC_000006 [ ENTREZ ]
RefSeqNT_007299 [ SRS ]    NT_007299 [ ENTREZ ]
RefSeqNW_923184 [ SRS ]    NW_923184 [ ENTREZ ]
AceViewDDX43 AceView - NCBI
UnigeneHs.125507 [ SRS ]    Hs.125507 [ NCBI ]     HS125507 [ spliceNest ]
Fast-db14443 (alternative variants)
Protein : pattern, domain, 3D structure
SwissProtQ9NXZ2 [ SRS]    Q9NXZ2 [ EXPASY ]     Q9NXZ2 [ INTERPRO ]
PrositePS00039 DEAD_ATP_HELICASE [ SRS ]    PS00039 DEAD_ATP_HELICASE [ Expasy ]
PrositePS51192 HELICASE_ATP_BIND_1 [ SRS ]    PS51192 HELICASE_ATP_BIND_1 [ Expasy ]
PrositePS51194 HELICASE_CTER [ SRS ]    PS51194 HELICASE_CTER [ Expasy ]
PrositePS50084 KH_TYPE_1 [ SRS ]    PS50084 KH_TYPE_1 [ Expasy ]
PrositePS51195 Q_MOTIF [ SRS ]    PS51195 Q_MOTIF [ Expasy ]
InterproIPR014001 DEAD-like_N [ SRS ]    IPR014001 DEAD-like_N [ EBI ]
InterproIPR001650 DNA/RNA_helicase_C [ SRS ]    IPR001650 DNA/RNA_helicase_C [ EBI ]
InterproIPR011545 DNA/RNA_helicase_DEAD/DEAH_N [ SRS ]    IPR011545 DNA/RNA_helicase_DEAD/DEAH_N [ EBI ]
InterproIPR014021 Helicase_SF1/SF2_ATP-bd [ SRS ]    IPR014021 Helicase_SF1/SF2_ATP-bd [ EBI ]
InterproIPR004087 KH [ SRS ]    IPR004087 KH [ EBI ]
InterproIPR004088 KH_type_1 [ SRS ]    IPR004088 KH_type_1 [ EBI ]
InterproIPR000629 RNA-helicase_DEAD-box_CS [ SRS ]    IPR000629 RNA-helicase_DEAD-box_CS [ EBI ]
InterproIPR014014 RNA_helicase_DEAD_Q_motif [ SRS ]    IPR014014 RNA_helicase_DEAD_Q_motif [ EBI ]
CluSTrQ9NXZ2
PfamPF00270 DEAD [ SRS ]    PF00270 DEAD [ Sanger ]    pfam00270 [ NCBI-CDD ]
PfamPF00271 Helicase_C [ SRS ]    PF00271 Helicase_C [ Sanger ]    pfam00271 [ NCBI-CDD ]
PfamPF00013 KH_1 [ SRS ]    PF00013 KH_1 [ Sanger ]    pfam00013 [ NCBI-CDD ]
SmartSM00487 DEXDc [EMBL]
SmartSM00490 HELICc [EMBL]
SmartSM00322 KH [EMBL]
BlocksQ9NXZ2
HPRD10448
Protein Interaction databases
DIPQ9NXZ2
IntActQ9NXZ2
Polymorphism : SNP, mutations, diseases
OMIM606286    [ map ]   
GENECLINICS606286
SNPDDX43 [dbSNP-NCBI]  
SNPNM_018665 [SNP-NCI]  
SNPDDX43 [GeneSNPs - Utah]  DDX43] [HGBASE - SRS]
HAPMAPDDX43 [HAPMAP]  
COSMICDDX43 [Somatic mutation (COSMIC-CGP-Sanger)]  
HGMDDDX43
General knowledge
Family BrowserDDX43 [UCSC Family Browser]
SOURCENM_018665
SMDHs.125507
SAGEHs.125507
Enzyme3.6.1.- [ Enzyme-SRS ]   3.6.1.- [ Brenda-SRS ]   3.6.1.- [ KEGG ]   3.6.1.- [ WIT ]
GOnucleotide binding [Amigo]  nucleotide binding
GORNA binding [Amigo]  RNA binding
GOATP-dependent RNA helicase activity [Amigo]  ATP-dependent RNA helicase activity
GOATP binding [Amigo]  ATP binding
GOintracellular [Amigo]  intracellular
GOhydrolase activity [Amigo]  hydrolase activity
PubGeneDDX43
TreeFamDDX43
CTD55510 [Comparative ToxicoGenomics Database]
Other databases
Probes
ProbeDDX43 Related clones (RZPD - Berlin)
PubMed
PubMed11 Pubmed reference(s) in LocusLink

Bibliography

Identification on a human sarcoma of two new genes with tumor-specific expression.
Martelange V, De Smet C, De Plaen E, Lurquin C, Boon T
Cancer research. 2000 ; 60 (14) : 3848-3855.
PMID 10919659
 
High frequency of autologous anti-melanoma CTL directed against an antigen generated by a point mutation in a new helicase gene.
Baurain JF, Colau D, van Baren N, Landry C, Martelange V, Vikkula M, Boon T, Coulie PG
Journal of immunology (Baltimore, Md. : 1950). 2000 ; 164 (11) : 6057-6066.
PMID 10820291
 
Frequent expression of HAGE in presentation chronic myeloid leukaemias.
Adams SP, Sahota SS, Mijovic A, Czepulkowski B, Padua RA, Mufti GJ, Guinn BA
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 2002 ; 16 (11) : 2238-2242.
PMID 12399967
 
Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands.
Nagel H, Laskawi R, Eiffert H, Schlott T
Molecular pathology : MP. 2003 ; 56 (4) : 226-231.
PMID 12890744
 
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

Contributor(s)

Written01-2007Etienne De Plaen

Citation

This paper should be referenced as such :
De Plaen E . DDX43 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 43). Atlas Genet Cytogenet Oncol Haematol. January 2007 .
URL : http://AtlasGeneticsOncology.org/Genes/DDX43ID40288ch6q13.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Wed Jul 2 08:23:01 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

j.l.huret@chu-poitiers.fr.